The AIDS Research Consortium of Atlanta is currently seeking 10 to 12 volunteers to help test the safety of a vaccine that shows the potential of reversing HIV viral loads in HIV-positive individuals.
The 77-week trial of a vaccine from GeoVax, a biotechnology company based in Smyrna, Ga., that specializes in developing an HIV vaccine, is the first of its kind.
This study is “the first therapeutic trial ever conducted using a promising HIV vaccine candidate from GeoVax, Inc.,” according to a May 18 press release from ARCA.
For Debra Snell, riding in the AIDS Vaccine 200 isn’t just a fundraiser for a good cause, but a way to reclaim a level of freedom and mobility she almost lost.
For Debra Snell, riding in the AIDS Vaccine 200 isn’t just a fundraiser for a good cause, but a way to reclaim a level of freedom and mobility she almost lost.
Agave restaurant gets an early start on Cinco de Mayo with ‘Cinco de Gayo,’ where a portion of today’s sales benefit the AIDS Research Consortium of Atlanta.